In the liver, different studies showed a significant impact of AZGP1 on fatty acid metabolism, such as accelerated lipolysis and reduced inflammation in non-alcoholic fatty liver disease (NAFLD) [15,16,17,18]. This evidence concerns the gene AZGP1 and metabolic dysfunction-associated steatotic liver disease.